SCHEMBL2726488

SCHEMBL2726488

Cc1csc([C@H]2CCCN2C(=O)c2cc(-c3nnc([C@@](C)(N)Cc4ccccc4)o3)ccn2)n1

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.39
HCRTR1 O43613 3/20 0.38
HCRTR2 O43614 3/20 0.38
AADAT Q8N5Z0 1/20 0.38
SCD O00767 4/20 0.38
PKM P14618 1/20 0.38
TRPV1 Q8NER1 1/20 0.37
CPT1A P50416 2/20 0.36
CPT2 P23786 1/20 0.36
SCD5 Q86SK9 4/20 0.36
BACE2 Q9Y5Z0 1/20 0.36
TRPC3 Q13507 1/20 0.35
TRPC6 Q9Y210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2726490 1.00 BACE1 (0.39) BACE1HCRTR1HCRTR2AADATSCD
SCHEMBL2726485 1.00 BACE1 (0.39) BACE1HCRTR1HCRTR2AADATSCD
SCHEMBL2727057 0.91 HCRTR1 (0.36) BACE1HCRTR1HCRTR2AADATTRPV1
SCHEMBL2727059 0.91 HCRTR1 (0.36) BACE1HCRTR1HCRTR2AADATTRPV1
SCHEMBL2726327 0.90 BACE1 (0.42) BACE1HCRTR1HCRTR2AADATTRPV1
SCHEMBL2726325 0.90 BACE1 (0.42) BACE1HCRTR1HCRTR2AADATTRPV1
SCHEMBL2726326 0.90 BACE1 (0.42) BACE1HCRTR1HCRTR2AADATTRPV1
SCHEMBL6468066 0.90 BACE1 (0.37) BACE1HCRTR1HCRTR2AADATSCD
SCHEMBL2725874 0.89 SCD5 (0.39) BACE1HCRTR1HCRTR2AADATSCD
SCHEMBL6466657 0.89 SCD5 (0.39) BACE1HCRTR1HCRTR2AADATSCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054510-A1 OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2012-04-26 WO claimed
WO-2012054510-A1 OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2012-04-26 WO disclosed